R&G PHARMASTUDIES CO., LTD.

Other languages R&G PharmaStudies Co., Ltd.

Equities

301333

CNE100005K44

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
44.49 ^CNY	+1.58%		+1.02%	-31.00%

04-21	R&G PharmaStudies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	R&G PharmaStudies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

R&G PharmaStudies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-21
R&G PharmaStudies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25
R&G PharmaStudies Co., Ltd.(XSEC:301333) added to S&P Global BMI Index	23-09-18
R&G PharmaStudies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29
Certain A Shares of R&G PharmaStudies Co., Ltd. are subject to a Lock-Up Agreement Ending on 3-AUG-2023.	23-08-02
R&G Pharmastudies Co., Ltd. Implements Final Cash Dividend on A Shares for 2022, Payable on 29 June 2023	23-06-20
R&G Pharmastudies Co., Ltd. Approves the Cash Dividend for the Year 2022	23-06-01
R&G Pharmastudies Co., Ltd. Proposes Cash Final Dividend for 2022	23-04-25
R&G PharmaStudies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24
R&G PharmaStudies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26
R&G PharmaStudies Co., Ltd. has completed an IPO in the amount of CNY 1.1832 billion.	22-07-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer